Background: Endothelial cell cultures contain caspase 3-containing microparticles
INTRODUCTION
Like other eukaryotic cells, endothelial cells release microparticles (MP; EMP: endothelial microparticles) in vitro [1] [2] [3] and in vivo [4] [5] [6] [7] . To which extent EMP originate from adherent or from detached endothelial cells, however, is a still unanswered question.
Previously, we reported a correlation between the numbers of detached cells and EMP in vitro [8] . Other investigators provided indications that EMP are released from adherent endothelial cells during detachment, and that endothelial cells "rapidly lost adhesion" immediately after release of EMP [9, 10] . Thus, EMP are presumed to originate from detaching and detached endothelial cells. However, Hamilton et al. showed that endothelial cells escape from complement-induced lysis by releasing C5b-9-enriched EMP [11] , suggesting that EMP release may contribute to survival by eliminating externally imposed stress.
Recently, we demonstrated that EMP from endothelial cell cultures contain substantial quantities of active (17 kDa) caspase 3 [8] . These data prompted us to hypothesize that adherent endothelial cells may also release caspase 3-containing EMP, and thus escape from internally imposed stress, detachment and apoptosis. If true, then inhibition of EMP release is expected to result in intracellular accumulation of caspase 3 in adherent cells, with increased cell detachment and apoptosis. To test this hypothesis, we treated endothelial cells with a sub-lethal concentration of the apoptotic agent staurosporin or the activator interleukin-1 (IL-1 ), without or with widely used inhibitors of microparticle release, i.e. Y-27632 and calpeptin [9, 12, 13] .
MATERIALS AND METHODS

Reagents and assays
Medium M199, penicillin, streptomycin and L-glutamine were from GibcoBRL (Life Technologies; Paisley, UK). Human serum and fetal calf serum (both heat inactivated during 30 minutes at 56 ºC; HuSi and FCSi, respectively) were from BioWhittaker (Walkersville, MD, USA). Human serum albumin (HSA) was obtained from Sanquin (Amsterdam, The Netherlands). Recombinant human interleukin (IL)-1 was from Sigma (St. Louis, MO, USA). Human recombinant basic fibroblast growth factor and epidermal growth factor were from Invitrogen life technologies (Carlsbad, CA, USA). Collagenase (type 1A) and staurosporin were from Sigma (St. Louis, MO, USA). Heparin (400 U/mL) was obtained from Leo Pharma BV (Breda, The Netherlands), trypsin from Difco Laboratories (Detroit, MI, USA), calpeptin from Calbiochem (La Jolla, CA, USA), and Y-27632 from Tocris (Ellisville, MO, USA). Y-27632 is a specific inhibitor of Rhoassociated serine/threonine kinases I and II (i.e. ROCK I (p160ROCK, ROK ) and ROCK II (Rho-kinase, ROK )), enzymes which are directly involved in the release of apoptotic blebs [9, 12] . Calpeptin inhibits calpain, a Ca 2+ -dependent protease, that plays a role in (E)MP formation [13] . For Western blot analysis, anti-human caspase 3 monoclonal antibody from Alexis Biochemicals (San Diego, CA, USA) and polyclonal goat-antimouse HRP conjugate (DAKO; Glostrup, Denmark) were used. Tissue culture flasks were from Greiner Labortechnik (Frickenhausen, Germany) and gelatin was from Difco
Laboratories (Sparks, MD, USA).
Isolation, culture and treatment of human umbilical vein endothelial cells (HUVEC)
HUVEC were collected as described previously [3] . Upon confluency at passage 3 in with annexin V-FITC (IQP; Groningen, The Netherlands) and propidium iodide (PI; a gift from Dr. E. Reits, Department of Cell Biology and Histology, AMC, The Netherlands) as described previously [8] . Intracellular caspase 3 was detected using the active caspase-3
MoAb apoptosis kit I from BD Pharmingen (San Diego, CA, USA). Samples were analyzed in a FACSCalibur flowcytometer (Becton Dickinson; San Jose, CA, USA). The cell number was estimated per culture flask using flow cytometry.
Isolation of EMP
Aliquots (1 mL) of the cell-free culture supernatants were snapfrozen in liquid nitrogen and stored at -80 °C. Before use, samples were thawed on melting ice for 1. 
Flow cytometric analysis of EMP
EMP were analyzed in a FACSCalibur flow cytometer as described previously [3] . 
Western blotting
Detached and adherent endothelial cells were separately isolated, washed and Mannheim, Germany).
Previously we showed that detached cell lysates from control and IL-1 -treated cultures contain 17 kDa caspase 3 [8] . The absence of detectable amounts of caspase 3 in detached cell lysates by Western blot in our present experiments should be interpreted as "below detection level" rather than being completely absent, since lesser numbers of detached cells were available due to the necessity of downscaling of the culture conditions compared to our previous studies as a consequence of the number of experimental conditions to be tested simultaneously.
Scanning Electron Microscopy (SEM)
HUVEC (third passage) were cultured on gelatin-coated coverslips. At 90% confluence, cells were incubated overnight without or with staurosporin (200 nM) or IL-1 (5 ng/mL). Specimens were prepared essentially as described by van Berkel et al. [14] . 
Figure 1. Basal conditions: endothelial cell cultures in the absence of inhibitors of microparticle release. Endothelial cells were incubated without (control) or with staurosporin (200 nM) or IL-1 (5 ng/mL) for 24 hours. Adherent cells (A, B), detached cells (C, D) and EMP (E) were isolated and analyzed as described in Methods, and their numbers were estimated by flow cytometry. Bars indicate median (range). Adherent cells (B) and detached cells (D) were analyzed for their apoptotic status by annexin V binding (open bars; 'early apoptosis') or by staining for both annexin V and PI (dashed bars; 'late apoptosis'). Bars indicate mean SD (n=3). In E, both annexin V-positive (dotted bars) and annexin V-negative EMP (lower bars) are shown (n=6).
Effects of inhibitors of microparticle release on endothelial detachment and EMP release
The effects of two widely used inhibitors of microparticle release (Y-27632, calpeptin) on cell detachment and EMP release were tested in endothelial cell cultures in the absence (control, untreated) or presence of external stress (staurosporin, IL-1 ) for 24 hours ( Figure 3A ), then it can be calculated from the data shown in Table 1 
) plus calpeptin (200 M). A. Fractions of detached cells. B and E show adherent (B) and detached (E) endothelial cell fractions binding annexin V as an indicator of apoptosis. C and F show adherent (C) and detached (F) endothelial cell fractions staining for intracellular caspase 3, whereas D and G show the 'total amounts' of 17 kDa caspase 3 detectable in lysates of adherent (D) and detached (G) endothelial cells in the absence (-) or presence (+) of Y-27632 plus calpeptin. H-J show the absolute numbers of caspase 3-containing EMP (H), the fractions of caspase 3-containing EMP (I) and western blots of EMP lysates of 17 kDa caspase 3 (J).
Effects of inhibitors of microparticle release in endothelial cell
Figure 3. Effects of inhibitors of microparticle release in endothelial cell cultures in the presence of external stress: staurosporin. Endothelial cell cultures (n=3) were incubated with additional external stress (staurosporin) up to 48 hours, in the absence (open symbols) or presence (closed symbols) of Y-27632 (30 M) plus calpeptin (200 M). A shows the fractions of detached cells. B and E show adherent (B) and detached (E) endothelial cell fractions binding annexin V. C and F show adherent (C) and detached (F) endothelial cell fractions staining for intracellular caspase 3, whereas D and G show the 'total amounts' of 17 kDa caspase 3 detectable in lysates of adherent (D) and detached (G) endothelial cells in the absence (-) or presence (+) of Y-27632 plus calpeptin. H-J show the absolute numbers of caspase 3-containing EMP (H), the fractions of caspase 3-containing EMP (I) and Western blots of EMP lysates of 17 kDa caspase 3 (J).
Effects of inhibitors
. Endothelial cell cultures (n=3) were incubated with additional external stress (IL-1 ) up to 48 hours, in the absence (open symbols) or presence (closed symbols) of Y-27632 (30 M) plus calpeptin (200 M). A shows the fractions of detached cells. B and E show adherent (B) and detached (E) endothelial cell fractions binding annexin V. C and F show adherent (C) and detached (F) endothelial cell fractions staining for intracellular caspase 3, whereas D and G show the 'total amounts' of 17 kDa caspase 3 detectable in lysates of adherent (D) and detached (G) endothelial cells in the absence (-) or presence (+) of Y-27632 plus calpeptin. H-J show the absolute numbers of caspase 3-containing EMP (H), the fractions of caspase 3-containing EMP (I) and Western blots of EMP lysates of 17 kDa caspase 3 (J).
The origin of EMP, attached or detached cells?
To with purified calpain reduced PIP 2 levels, whereas in the presence of calpeptin the PIP 2 levels increased [18] . This indicates that calpeptin may influence PIP 2 levels by calpain independent from its calcium-dependent protease activity.
Endothelial cells can also detach by caspase-independent mechanisms, and cell death of detached cells is then a consequence of detachment (anoikis) of originally viable endothelial cells. For example, Hasmim and coworkers showed that expression of integrin cytoplasmic domains in endothelial cells induced caspase-independent detachment that was followed by anoikis [19] . Our present data also indicate that detached cells only become apoptotic some time after detachment.
Taken together, we postulate that the release of EMP is a general mechanism to enable cells to dispose potentially harmful and redundant compounds, thereby supporting cellular survival. Unfortunately, this hypothesis can not presently be tested directly, because we have no specific markers available to distinguish EMP originating from adherent cells and detaching/detached cells. 
